{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:48Z","timestamp":1786990308152,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","id.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.idc.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T12:18:05Z","timestamp":1432037885000},"page":"309-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Posttreatment Lyme Disease Syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"John N.","family":"Aucott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(03)00308-5","article-title":"Long-term follow-up of patients with culture-confirmed Lyme disease","volume":"115","author":"Nowakowski","year":"2003","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.idc.2015.02.012_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.idc.2007.12.011","article-title":"Chronic Lyme disease: a review","volume":"22","author":"Marques","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.idc.2015.02.012_bib4","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/IAI.61.7.2774-2779.1993","article-title":"Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi","volume":"61","author":"Kalish","year":"1993","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","article-title":"Treatment of the early manifestations of Lyme disease","volume":"99","author":"Steere","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2015.02.012_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-124-9-199605010-00002","article-title":"Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial","volume":"124","author":"Luft","year":"1996","journal-title":"Ann Intern Med"},{"issue":"11\u201312","key":"10.1016\/j.idc.2015.02.012_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00508-005-0361-8","article-title":"A\u00a0comparison of two treatment regimens of ceftriaxone in late Lyme disease","volume":"117","author":"Dattwyler","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib9","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.idc.2015.02.012_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2334-9-79","article-title":"Diagnostic challenges of early Lyme disease: lessons from a community case series","volume":"9","author":"Aucott","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with Lyme disease, 10-20-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J\u00a0Infect Dis"},{"issue":"8728","key":"10.1016\/j.idc.2015.02.012_bib12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/0140-6736(90)93103-V","article-title":"Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis","volume":"336","author":"Dattwyler","year":"1990","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idc.2015.02.012_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-117-4-273","article-title":"Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease","volume":"117","author":"Nadelman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.idc.2015.02.012_bib14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.1996.03530450047031","article-title":"Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness","volume":"275","author":"Krause","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib15","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cid\/cit735","article-title":"Elevated levels of IL-23 in a subset of patients with post-Lyme disease symptoms following erythema migrans","volume":"58","author":"Strle","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2015.02.012_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.idc.2015.02.012_bib17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-131-12-199912210-00003","article-title":"Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease","volume":"131","author":"Shadick","year":"1999","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.idc.2015.02.012_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-138-9-200305060-00005","article-title":"Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Wormser","year":"2003","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.idc.2015.02.012_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1086\/649920","article-title":"Antibiotic treatment duration and long-term outcomes of patients with early Lyme disease from a Lyme disease-hyperendemic area","volume":"50","author":"Kowalski","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y Follow-up study of patients with neuroborreliosis","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib21","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.51.5.1489","article-title":"Clinical and serologic follow-up in patients with neuroborreliosis","volume":"51","author":"Treib","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","article-title":"Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors","volume":"17","author":"Lj\u00f8stad","year":"2010","journal-title":"Eur J Neurol"},{"issue":"13","key":"10.1016\/j.idc.2015.02.012_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A\u00a0randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11136-012-0126-6","article-title":"Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?","volume":"22","author":"Aucott","year":"2013","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib26","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.ijid.2013.01.008","article-title":"Development of a foundation for a case definition of post-treatment Lyme disease syndrome","volume":"17","author":"Aucott","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.psym.2013.04.003","article-title":"Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy","volume":"54","author":"Chandra","year":"2013","journal-title":"Psychosomatics"},{"issue":"9","key":"10.1016\/j.idc.2015.02.012_bib28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciu106","article-title":"Lyme disease: neurology, neurobiology, and behavior","volume":"58","author":"Halperin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7568","key":"10.1016\/j.idc.2015.02.012_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib30","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/ije\/dyi129","article-title":"Post-lyme borreliosis syndrome: a meta-analysis of reported symptoms","volume":"34","author":"Cairns","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"7","key":"10.1016\/j.idc.2015.02.012_bib31","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1172\/JCI58813","article-title":"Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy","volume":"122","author":"Bockenstedt","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10067-012-1964-x","article-title":"The amber theory of Lyme arthritis: initial description and clinical implications","volume":"31","author":"Wormser","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"1\u20132","key":"10.1016\/j.idc.2015.02.012_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.10.011","article-title":"Increased IFN\u03b1 activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits","volume":"255","author":"Jacek","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib34","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbi.2010.03.002","article-title":"Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms","volume":"24","author":"Chandra","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/CVI.00002-11","article-title":"Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome","volume":"18","author":"Chandra","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.idc.2015.02.012_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1056\/NEJM199007263230402","article-title":"Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles","volume":"323","author":"Steere","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"5377","key":"10.1016\/j.idc.2015.02.012_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib38","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.34383","article-title":"Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis","volume":"64","author":"Strle","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib39","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ajpath.2011.02.018","article-title":"Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease","volume":"178","author":"Strle","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib40","doi-asserted-by":"crossref","first-page":"e29914","DOI":"10.1371\/journal.pone.0029914","article-title":"Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection","volume":"7","author":"Embers","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib41","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2015.02.012_bib42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1086\/345284","article-title":"Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment","volume":"186","author":"Bockenstedt","year":"2002","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2015.02.012_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/cid\/cit939","article-title":"Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study","volume":"58","author":"Marques","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","article-title":"Long-term outcomes of persons with Lyme disease","volume":"283","author":"Seltzer","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib45","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1542\/peds.112.2.e93","article-title":"Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease","volume":"112","author":"V\u00e1zquez","year":"2003","journal-title":"Pediatrics"},{"issue":"RR-10","key":"10.1016\/j.idc.2015.02.012_bib46","first-page":"1","article-title":"Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"issue":"1209","key":"10.1016\/j.idc.2015.02.012_bib47","first-page":"41","article-title":"Treatment of Lyme disease","volume":"47","author":"Medical Letter","year":"2005","journal-title":"Med Lett Drugs Ther"},{"issue":"21","key":"10.1016\/j.idc.2015.02.012_bib48","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.idc.2015.02.012_bib49","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1288\/00005537-198511000-00009","article-title":"Facial paralysis in Lyme disease","volume":"95","author":"Clark","year":"1985","journal-title":"Laryngoscope"},{"key":"10.1016\/j.idc.2015.02.012_bib50","doi-asserted-by":"crossref","first-page":"525206","DOI":"10.1155\/2010\/525206","article-title":"Lyme neuroborreliosis: preliminary results from an urban referral center employing strict CDC criteria for case selection","volume":"2010","author":"Younger","year":"2010","journal-title":"Neurol Res Int"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib51","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cppeds.2013.12.014","article-title":"Adolescent fatigue, POTS, and recovery: a guide for clinicians","volume":"44","author":"Kizilbash","year":"2014","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib52","first-page":"63","article-title":"Postural orthostatic tachycardia syndrome following Lyme disease","volume":"18","author":"Kanjwal","year":"2011","journal-title":"Cardiol J"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.34.1.1-9.1996","article-title":"Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans","volume":"34","author":"Aguero-Rosenfeld","year":"1996","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of Lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib55","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1086\/322669","article-title":"Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease","volume":"33","author":"Kalish","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2015.02.012_bib56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10096-004-1163-z","article-title":"Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis","volume":"23","author":"Fleming","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2015.02.012_bib57","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3201\/eid0804.010222","article-title":"Outcomes of treated human granulocytic ehrlichiosis cases","volume":"8","author":"Ramsey","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib58","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1086\/317465","article-title":"Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease","volume":"31","author":"Wang","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib59","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3174\/ajnr.A1579","article-title":"Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis","volume":"30","author":"Hildenbrand","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib60","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archgenpsychiatry.2009.29","article-title":"Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy","volume":"66","author":"Fallon","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/314860","article-title":"Successful treatment of Lyme encephalopathy with intravenous ceftriaxone","volume":"180","author":"Logigian","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.idc.2015.02.012_bib62","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMra072023","article-title":"A\u00a0critical appraisal of \u201cchronic Lyme disease\u201d","volume":"357","author":"Feder","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9343(90)90520-N","article-title":"Summary of the first 100 patients seen at a Lyme disease referral center","volume":"88","author":"Sigal","year":"1990","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.idc.2015.02.012_bib64","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/clind\/16.4.558","article-title":"Experience at a referral center for patients with suspected Lyme disease in an area of nonendemicity: first 65 patients","volume":"16","author":"Burdge","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-2334-12-173","article-title":"Probable late Lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection","volume":"12","author":"Aucott","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2015.02.012_bib66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-128-5-199803010-00003","article-title":"The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study","volume":"128","author":"Reid","year":"1998","journal-title":"Ann Intern Med"},{"issue":"14","key":"10.1016\/j.idc.2015.02.012_bib67","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1001\/jama.1993.03500140064037","article-title":"The overdiagnosis of Lyme disease","volume":"269","author":"Steere","year":"1993","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.idc.2015.02.012_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-117-4-281","article-title":"Lyme disease associated with fibromyalgia","volume":"117","author":"Dinerman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.idc.2015.02.012_bib69","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/archneur.1997.00550230045015","article-title":"Post-lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences","volume":"54","author":"Gaudino","year":"1997","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.idc.2015.02.012_bib70","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.neuropsych.12090223","article-title":"Post-treatment Lyme syndrome and central sensitization","volume":"25","author":"Batheja","year":"2013","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"9","key":"10.1016\/j.idc.2015.02.012_bib72","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1473-3099(11)70034-2","article-title":"Antiscience and ethical concerns associated with advocacy of Lyme disease","volume":"11","author":"Auwaerter","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib73","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0031-1287652","article-title":"Nervous system Lyme disease: is there a controversy?","volume":"31","author":"Halperin","year":"2011","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib74","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.amjmed.2013.09.005","article-title":"Ongoing discussion about the US clinical Lyme trials","volume":"127","author":"Fallon","year":"2014","journal-title":"Am J Med"},{"issue":"6 Suppl 69","key":"10.1016\/j.idc.2015.02.012_bib75","first-page":"S97","article-title":"Effectiveness of multidisciplinary therapy on symptomatology and quality of life in women with fibromyalgia","volume":"29","author":"Carbonell-Baeza","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mcna.2006.10.008","article-title":"Behavioral medicine approaches to pain","volume":"91","author":"Okifuji","year":"2007","journal-title":"Med Clin North Am"},{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pmr.2005.12.004","article-title":"Multidisciplinary and interdisciplinary management of chronic pain","volume":"17","author":"Stanos","year":"2006","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"4","key":"10.1016\/j.idc.2015.02.012_bib78","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.apmr.2010.11.015","article-title":"Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008","volume":"92","author":"Cicerone","year":"2011","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.idc.2015.02.012_bib79","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.arr.2010.11.003","article-title":"Cognitive intervention for persons with mild cognitive impairment: a meta-analysis","volume":"10","author":"Li","year":"2011","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib80","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1191\/1352458503ms904oa","article-title":"Fatigue associated with multiple sclerosis: diagnosis, impact and management","volume":"9","author":"Bakshi","year":"2003","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.idc.2015.02.012_bib81","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1517\/14656566.8.11.1629","article-title":"Treatment of fibromyalgia and its symptoms","volume":"8","author":"Staud","year":"2007","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1188\/07.CJON.99-113","article-title":"Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment","volume":"11","author":"Mitchell","year":"2007","journal-title":"Clin J Oncol Nurs"},{"issue":"10","key":"10.1016\/j.idc.2015.02.012_bib83","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1002\/art.22131","article-title":"Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis","volume":"54","author":"Steere","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.idc.2015.02.012_bib84","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1002\/1529-0131(199912)42:12<2705::AID-ANR29>3.0.CO;2-H","article-title":"Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis","volume":"42","author":"Carlson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.idc.2015.02.012_bib85","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/art.30384","article-title":"Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or Lyme arthritis","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.idc.2015.02.012_bib86","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/art.38618","article-title":"Antibodies to endothelial cell growth factor and obliterative microvascular lesions in synovia of patients with antibiotic-refractory Lyme arthritis","volume":"66","author":"Londo\u00f1o","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib87","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.37732","article-title":"A\u00a0novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease","volume":"65","author":"Drouin","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.idc.2015.02.012_bib88","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.1780340817","article-title":"Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy","volume":"34","author":"Schoen","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.idc.2015.02.012_bib89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides: an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.idc.2015.02.012_bib90","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2014.08.001","article-title":"Doxycycline exerts multiple anti-allergy effects to attenuate murine allergic conjunctivitis and systemic anaphylaxis","volume":"91","author":"Su","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.idc.2015.02.012_bib91","first-page":"904","article-title":"Treatment of ocular rosacea with 40 mg doxycycline in a slow release form","volume":"9","author":"Pfeffer","year":"2011","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"6","key":"10.1016\/j.idc.2015.02.012_bib92","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000235550","article-title":"Tetracycline actions relevant to rosacea treatment","volume":"22","author":"Korting","year":"2009","journal-title":"Skin Pharmacol Physiol"},{"issue":"7","key":"10.1016\/j.idc.2015.02.012_bib93","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1038\/emi.2014.53","article-title":"Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library","volume":"3","author":"Feng","year":"2014","journal-title":"Emerg Microbes Infect"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552015000306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552015000306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T23:18:01Z","timestamp":1717888681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552015000306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0891552015000306"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2015.02.012","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posttreatment Lyme Disease Syndrome","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}